Jakiri, Kasla .

HRN: 28-69-37  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/14/2026
METRONIDAZOLE 500MG (TAB)
03/14/2026
03/21/2026
PO
500mg
TID
NSVD ID
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: